share_log

HC Wainwright & Co. Reiterates Buy on Atossa Therapeutics, Maintains $4 Price Target

Moomoo 24/7 ·  Apr 16 11:01

HC Wainwright & Co. analyst Emily Bodnar reiterates Atossa Therapeutics (NASDAQ:ATOS) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment